Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.
Dec 1 2007
We examined the incidence of and risk factors for tuberculosis during the first year of highly active antiretroviral therapy in low-income (4540 patients) and high-income (22,217 patients) countries. Although incidence was much higher in low-income countries, the reduction in the incidence of tuberculosis associated with highly active antiretroviral therapy was similar: the rate ratio for months 7-12 versus months 1-3 was 0.48 (95% confidence interval, 0.36-0.64) in low-income countries and 0.36 (95% confidence interval, 0.26-0.50) in high-income countries. A low CD4 cell count at the start of therapy was the most important risk factor in both settings.
- Determination of the incidence of tuberculosis in low-income countries. [Clin Infect Dis. 2008]
PMID: 17990236 [PubMed - indexed for MEDLINE]